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Introduction: Gene expression profiling was performed via DNA microarrays in leukocytes from critically ill trauma
patients nonseptic upon admission to the ICU, who subsequently developed either sepsis (n = 2) or severe sepsis
and acute respiratory distress syndrome (n = 3). By comparing our results with published expression profiling
studies in animal models of sepsis and lung injury, we found aquaporin-1 to be differentially expressed across all
studies. Our aim was to determine how the water channel aquaporin-1 is involved in regulating the immune
response in critically ill patients during infection acquired in the ICU.
Methods: Following the results of the initial genetic screening study, we prospectively followed aquaporin-1
leukocyte expression patterns in patients with ICU-acquired sepsis who subsequently developed septic shock
(n = 16) versus critically ill patients who were discharged without developing sepsis (n = 13). We additionally
determined aquaporin-1 expression upon lipopolysaccharide (LPS) exposure and explored functional effects of
aquaporin-1 induction in polymorphonuclear granulocytes (PMNs).
Results: Leukocyte aquaporin-1 expression was induced at the onset of sepsis (median 1.71-fold increase;
interquartile range: 0.99 to 2.42, P = 0.012 from baseline) and was further increased upon septic shock (median
3.00-fold increase; interquartile range: 1.20 to 5.40, P = 0.023 from sepsis, Wilcoxon signed-rank test); no difference
was observed between baseline and discharge in patients who did not develop sepsis. Stimulation of PMNs by LPS
led to increased expression of aquaporin-1 in vitro, which could be abrogated by the NF-κB inhibitor EF-24. PMN
hypotonic challenge resulted in a transient increase of the relative cell volume, which returned to baseline after 600
seconds, while incubation in the presence of LPS resulted in persistently increased cell volume. The latter could be
abolished by blocking aquaporin-1 with mercury and restored by incubation in β-mercaptoethanol, which
abrogated the action of mercury inhibition.
Conclusions: Aquaporin-1 is induced in leukocytes of patients with ICU-acquired sepsis and exhibits higher
expression in septic shock. This phenomenon may be due to LPS-triggered NF-κB activation that can also lead to
alterations in plasma membrane permeability.Introduction
Septic shock, the most severe stage of the septic process,
is a deadly disease defined as severe sepsis with hy-
potension that persists after resuscitation with intravenous
fluid [1,2]. Critically ill patients may display a state of func-
tional immune system suppression, which predisposes* Correspondence: sorfanos@med.uoa.gr
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reproduction in any medium, provided the orthem to infections with opportunistic bacteria found in
the ICU environment [3] and results in excess morbidity
and mortality.
To identify genes and/or cellular pathways involved in
the pathogenesis of ICU-acquired sepsis, we initially under-
took leukocyte genomic expression analysis of polytrauma
patients who developed severe sepsis during their ICU stay
as compared with trauma patients who suffered from sep-
sis not escalating to a higher septic stage [2,4]. Following
robust statistical selection of differentially expressed genes,
results were compared with publicly available microarray
datasets, thus creating a unique list of likely diseasel Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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water channel protein [5,6], was one of the three genes
found deregulated in all datasets.
Aqp1, a 28 kDa integral membrane protein [7], exists as
a tetramer with intracellular N-termini and C-termini –
an organization similar to several ion channel proteins [8].
The functional significance of Aqp1 in migratory cells lies
presumably in cell volume regulation and cytokinesis
[9,10]. Aquaporin-9, an isoform of Aqp1, is constitutively
expressed and regulates water influx at the leading edge of
migrating neutrophils [11]. However, the role of Aqp1 in
the molecular events taking place after leukocyte activa-
tion by pathogens remains unclear.
Based on the findings of the genomic expression ana-
lysis of our initial polytrauma patient group, we hypoth-
esized that Aqp1 expression is induced in leukocytes of
critically ill patients afflicted with nosocomial sepsis in a
manner dependent on sepsis severity. To address this
hypothesis and to study potential underlying mecha-
nisms, we measured levels of leukocyte Aqp1 expression
in critically ill patients at ICU admission, upon diagno-
sis of sepsis and at occurrence of septic shock; in add-
itional in vitro experiments we probed the capacity of
lipopolysaccharide (LPS) to regulate Aqp1 expression in
polymorphonuclear granulocytes (PMNs) and investi-
gated potential signaling pathways and functions.
Materials and methods
The study was approved by the Evangelismos Hospital
Research Ethics Committee and all procedures carried
out on patients were in compliance with the Helsinki
Declaration. Ιnformed written consent was obtained
from all patients’ next-of–kin prior to any study
procedure.
Gene expression profiling study population
We initially screened consecutive admissions of poly-
trauma patients to the Evangelismos Hospital ICU, Athens,
Greece. Exclusion criteria were: no consent to participate,
sepsis upon ICU admission, body mass index >35 kg/m2,
age <18 years, pregnancy, brain death, end-stage cancer,
total ICU stay <3 days, re-admission or transfer from an-
other ICU, contagious diseases (human immunodeficiency
virus, hepatitis), and oral intake of corticosteroids at an
equivalent dosage ≥1 mg/kg prednisone/day for a period >1
month. The first five initially nonseptic patients (one
female), who subsequently became septic were included in
the study. Two blood samples were obtained per patient:
the first upon admission to the ICU, and the second within
48 hours of sepsis. Total RNA was isolated and cRNAs
were hybridized to Affymetrix Hu133A 2.0 GeneChips
Affymetrix, Santa Clara, CA, USA according to the manu-
facturer’s instructions. This dataset has been deposited in
ArrayExpress [ArrayExpress:E-MEXP-3621]. All methodsemployed in the aforementioned gene expression profiling
study are described in detail in Additional file 1.
Aqp1 gene expression in septic ICU patients: study
population
Following the initial microarray study stated above, we
sought to investigate Aqp1 leukocyte expression in critic-
ally ill adult, initially nonseptic, patients who were admitted
to the multi-disciplinary ICU of Evangelismos Hospital and
who subsequently developed sepsis and deteriorated to
septic shock; an additional group of patients who did
not develop sepsis during their stay in the ICU served as
the control.
Prior to enrollment, we screened all consecutive admis-
sions over a 12-month period for eligibility. Exclusion cri-
teria were the same as those used for our initial gene
expression profiling study population (above). Of the 118
subjects screened over the study period, finally 29 medical,
surgical and trauma patients were enrolled in the study,
16 of whom developed septic shock and 13 who served as
our control patients (did not develop sepsis during their
stay in the ICU). Clinical data and blood samples were
obtained from all patients enrolled. Patients were consid-
ered to have sepsis when they developed systemic inflam-
matory response syndrome as a result of documented
infection, septic patients with evidence of organ dysfunc-
tion were considered to have severe sepsis, and septic
patients with persisting hypotension (despite adequate
fluid resuscitation) were considered to have septic shock,
in accordance with international guidelines and recom-
mendations [2,4].
Following study enrollment, baseline (upon ICU admis-
sion) anthropometric data and detailed organ system-
oriented medical history were recorded. A venous blood
sample was drawn at three different time points: at the
time of ICU admission (baseline), at the onset of sepsis
(within 6 to 12 hours) and upon septic shock. In patients
who did not develop sepsis, blood samples were drawn at
admission and at ICU discharge only. The age of the septic
patients ranged from 21 to 82 years whereas the age of the
patients that did not develop sepsis varied from 31 to 82
years. The characteristics of the abovementioned patients
are presented in Table 1.
Chemicals and reagents
Whole blood was collected in Tempus Blood RNA tubes
(Applied Biosystems, Life Technologies Corporation,
Carlsbad, CA, USA). RNA extraction was performed with
the Tempus spin RNA isolation kit (Applied Biosystems,
Life Technologies Corporation). Taq DNA polymerase was
purchased from Fermentas (Thermo Fisher Scientific Inc.,
Waltham, MA, USA), reverse transcriptase from New
England Biolabs (Ipswich, MA, USA), the SYBR-Green
assay from Finnzymes (Thermo Fisher Scientific,
Table 1 Characteristics of the two ICU patient groups
Characteristic Sepsis/septic shock Nonsepsis P value
Number of patients 16 13
Age (years) 47 ± 18 57 ± 17 0.12
Gender
Male 13 (81.3%) 6 (46.2%) 0.06
Female 3 (18.7%) 7 (53.8%)
Diagnosis
Medical 5 (31.3%) 5 (38.5%) 0.71
Surgical or trauma 11 (68.7%) 8 (61.5%)
ICU mortality 6 (37.5%) 0 (0%) 0.02
APACHE II score 15.3 ± 6.0 14.6 ± 5.0 0.76
SOFA score 8.3 ± 2.3 5.2 ± 1.8 <0.001
Sepsis day 4.2 ± 1.8 N/A
Septic shock day 12.7 ± 10.0 N/A
Data expressed as number (percentages) of total related variable and mean ±
standard deviation. Student’s t test or the chi-square test was used, as
appropriate. APACHE II and SOFA scores were estimated at ICU admission;
sepsis and septic shock days denote the days post-ICU admission when sepsis
and septic shock developed, respectively. APACHE, Acute Physiology and
Chronic Health Evaluation; SOFA, Sequential Organ Failure Assessment.
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the NF-κB (p65) transcription factor assay kit from Cay-
man Chemical Company (Ann Arbor, MI, USA). LPS, EF-
24, dithiothreitol (DTT) and phenylmethylsulfonyl fluoride
were from Sigma (Sigma-Aldrich Corp, St Louis, MO,
USA). The PCR products were analyzed by agarose gel
electrophoresis. All reagents used were of analytical grade.
Blood collection
Three milliliters of venous blood were collected within the
first 24 hours post ICU admission, at the onset of sepsis
(within 6 to 12 hours) and upon septic shock or discharge
from the ICU. Samples were collected in tubes containing
RNA stabilizing solution (Applied Biosystems, Life Tech-
nologies Corporation).
Total RNA extraction and evaluation of its quality
Total RNA was isolated from total blood cells (>95% leu-
kocytes) using the Tempus spin RNA isolation kit (Applied
Biosystems, Life Technologies Corporation) and following
the manufacturer's instructions. Total RNA concentration
and quality were determined spectrophotometrically at 260
and 280 nm, while RNA integrity was evaluated with for-
maldehyde agarose gel electrophoresis. Total RNA was
stored at −80°C until use.
Reverse transcription and PCR
One microgram of total RNA from each sample was re-
verse transcribed into single-stranded cDNA in a 20 μl re-
action mixture, using the M-MuLV Reverse Transcriptase(New England Biolabs, Ipswich, MA, USA) and Oligo(dT)
primers, following the manufacturer's instructions. The
success of the synthesis of the single-stranded cDNA was
tested by its PCR amplification. PCR was performed using
1.0 μl cDNA, 1.5 mM MgCl2, 400 μM dNTPs, 500 nM
primers, 1.5 U Dream-Taq DNA polymerase and 1× reac-
tion buffer (Fermentas, Thermo Fisher Scientific Inc.), on
a PTC-200 thermocycler (MJ Research Inc., Waltham,
MA, USA). Equal amounts (10 μl) of the 108 bp glyceral-
dehyde 3-phosphate dehydrogenase (GAPDH) and the
177 bp Aqp1 products were electrophoresed on a 2.5%
agarose gel, visualized following ethidium bromide stain-
ing and photographed under ultraviolet light with a Kodak
DC120 digital camera (Rochester, NY, USA).
Quantitative real-time PCR
A highly sensitive quantitative real-time PCR method has
been developed for the quantification of both GAPDH and
Aqp1 mRNAs, with the use of SYBRW Green Dye detection
systems. For the amplification of GAPDH (endogenous ref-
erence gene) as well as Aqp1 (target gene) mRNA se-
quences, gene-specific sets of primers were designed
according to the information on the NCBI Sequence data-
base and the advanced software of the Primer Express pro-
gram. To avoid genomic DNA amplification, the primers,
mentioned above, were chosen to span at least two exons.
The sequences of the primers used were: for GAPDH,
the forward 5′-ATGGGGAAGGTGAAGGTCG-3′ primer,
consisting of 19 nucleotides, and the reverse 23-nucleotide
5′-TACATGAGGGCACGGAAGATG-3′ primer, which
gave rise to a 108 bp amplicon; for the Aqp1 gene, the
forward 5′-GGTGGGGAACAACCAGACG-3′ primer and
the reverse 5′-TACATGAGGGCACGGAAGATG-3′ pri-
mer, each with a length of 23 nucleotides, produced an
amplicon of 177 bp.
Quantitative real-time PCR analysis was performed in
96-well plates on a PTC-200 thermocycler (MJ Research
Inc.). The 25 μl reaction mixture contained 5 ng cDNA,
300 nM primers and 1× DyNAmo SYBRW Green PCR
Master Mix (Finnzymes, Thermo Fisher Scientific), in
which modified Tbr DNA polymerase is included. The
thermal protocol conditions consisted of 2 minutes at 50°C
and 10 minutes at 95°C polymerase activation step, 40
cycles of denaturation at 95°C for 15 seconds, primer
annealing at 54°C for 30 seconds, extension at 72°C for 10
seconds and a final extension step at 72°C for 10 minutes.
All samples were amplified in triplicate and the average
CT values were calculated for their subsequent expression
analysis. Following amplification, a dissociation curve was
generated to distinguish the PCR products of interest from
the nonspecific ones or any primer dimers, through their
particular melting temperatures (Tm), recorded in the soft-
ware. Using the comparative 2−ΔΔCT method [12] and the
baseline samples as a calibrator, the relative quantification
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out. GAPDH expression was used for the normalization of
Aqp1 expression levels between the different samples.
Polymorphonuclear granulocyte isolation
PMNs were isolated from peripheral blood of consecutive
healthy volunteers – blood donors supplied by the Blood
Bank of Evangelismos Hospital. Blood was collected in 17%
citric acid and allowed to sediment in 3% Dextran/0.9%
NaCl for 1 hour. Leukocyte-rich supernatant was separated
by centrifugation on Histopaque (Sigma, Sigma-Aldrich
Corp.). After lysis of residual erythrocytes by hypotonic
shock in ice-cold distilled water, the cells were resuspended
in Hank's balanced salt solution (Gibco, Life Technologies
Corporation, Carlsbad, CA, USA) and stored on ice until
use. The cells were counted and diluted to the desired
concentration.
Culture of polymorphonuclear granulocytes
PMNs (2×106) were cultured in Hank’s balanced salt so-
lution using six-well plates. LPS from Pseudomonas
aeruginosa 10 (Sigma, Sigma-Aldrich Corp.) was added
at a final concentration of 100 ng/ml in the absence or
presence of 1 μM NF-κΒ inhibitor EF-24 (Sigma, Sigma-
Aldrich Corp.). The cells were incubated for 3 hours at
37°C. Following incubation, the cells were harvested for
RNA and/or protein isolation. Each experiment was in-
dependently performed five times.
RNA isolation from polymorphonuclear cells
RNA extraction was performed using the TrizolW reagent
and the PureLink RNA Mini kit (Invitrogen, Life Technolo-
gies Corporation) following the manufacturer’s instructions.
RNA was stored at −80°C until use. Reverse transcription
and quantitative real-time PCR were performed as de-
scribed above.Polymorphonuclear cell homogenate
Approximately 2×106 cells were homogenized in PBS
buffer with the addition of 5 μM DTT, 0.1 mM phenyl-
methylsulfonyl fluoride in isopropanol, and protease in-
hibitors, using a sonicator (Sonic Dismembrator 550;
Fisher Scientific, Loughborough, UK) and 3×10 second
bursts. The homogenate was centrifuged in a 5804 R
Eppendorf centrifuge (rotor A-4-44; Eppendorf AG,
Hamburg, Germany) for 5 minutes at 4°C and 1,000×g.
The supernatant, referred to as total protein, was col-
lected and stored at −80°C until use.Protein determination
Total protein concentration was determined according
to the method of bicinchonic acid [13], using bovine
serum albumin as standard.SDS-polyacrylamide gel electrophoresis
SDS-PAGE was performed on a Biorad Mini Protean II
electrophoresis apparatus (Bio-Rad, Hercules, CA, USA),
as described [14], using 12% polyacrylamide slab gels.
Electrophoresis was carried out at 150 V for 1 hour at
room temperature.
Immunoblotting of polymorphonuclear homogenates
with Aqp1 antibody
Following electrophoresis, samples were transferred onto
an Immobilon-P polyvinylidene difluoride membrane
(Millipore, 0.45 μl pore size; Millipore Corporation, Biller-
ica, MA, USA). Western transfer was performed on a wet
transfer apparatus (Bio-Rad). Immunological detection
was performed according to the method of Batteiger and
colleagues [15]. The polyclonal antibody against Aqp1
purchased from Santa Cruz Biotechnology, Inc. (Santa
Cruz Biotechnology, Inc., Dallas, TX, USA) was used for
the detection.
Cell volume measurements
Osmotic swelling was monitored as in [16] with slight
modifications. Briefly, swelling was monitored at 22°C
with a Zeiss Axiovert 25 phase contrast microscope (Carl
Zeiss AG, Oberkochen, Germany) with two 10× eyepieces
and a 40× objective on a trinocular base, 0.5-numerical
aperture long working distance Canon objective equipped
with a Canon digital camera (Canon USA Inc., Melville,
NY, USA). PMN were transferred from 300 mosM (in) to
150 mosM (out) Hank’s balanced salt solution diluted with
water. PMN images were taken at 30-second intervals for
a total of 600 seconds or until the time of PMN rupture.
The relative volume V/Vo, that is the ratio of measured
volume at various time-points during the osmotic
challenge to the baseline volume, was determined.
Changes in volume were measured by ImageJ software
(NIH, Bethesda, MD, USA).
Cytokine measurement
IL-8 levels were measured at the supernatants of the
PMN cells by ELISA, according to the manufacturer’s in-
structions. The human IL-8 immunoassay of R&D Sys-
tems Inc. (Minneapolis, MN, USA) was used. This assay
uses two different polyclonal antibodies against the cyto-
kines as the catching antibody and the tagging antibody.
Samples were assayed in triplicate.
Polymorphonuclear cell nuclear extraction
Nuclear extraction was performed with the kit by Cayman
Chemical Company, according to the manufacturer’s in-
structions. In brief, approximately 2×106 cells were ho-
mogenized in pre-extraction buffer containing DTT and
protease inhibitors. The cytoplasmic extract was removed
from the nuclear pellet, which was treated further with
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The extract was incubated on ice for 15 minutes with vor-
tex (5 seconds) every 3 minutes. The suspension was
centrifuged in an Espresso centrifuge (Thermo Fisher
Scientific Inc.) for 10 minutes at 9,800×g at 4°C and trans-
ferred into a new microcentrifuge vial. The supernatant,
referred to as nuclear extract, was used for the measure-
ment of NF-κB activation. Total protein concentration
was determined by the bicinchonic acid method, as men-
tioned in the Protein determination section above.
NF-κB transcription factor activation measurement
The activation of NF-κB transcription factor was mea-
sured for the nuclear extracts of PMN cells by the Tran-
scription Factor Assay kit (Cayman Chemical Company),
according to the manufacturer’s instructions. A specific
double-stranded DNA sequence containing the NF-κB
response element is immobilized onto the bottom of
wells of a 96-well plate. NF-κB contained in a nuclear
extract binds specifically to the NF-κB response element.
NF-κB (p65) is detected by addition of specific primary
antibody directed against NF-κB (p65). A secondary
antibody conjugated to horseradish peroxidase is added
to provide a sensitive colorimetric readout at 450 nm.
Samples were assayed in triplicate.
Statistical analysis
Data are presented as individual values, mean ± standard
deviation for normally distributed variables and median
with interquartile range for variables with skewed distri-
bution. For continuous variables, the t test was used for
two-group comparisons. Associations between qualita-
tive variables were examined by the chi-square test. The
Friedman test was used to examine differences within
more than two groups, and the Wilcoxon signed-rank
test for differences within two groups, one-way and two-
way analyses of variance for repeated measures and
Kruskal–Wallis analysis of variance followed by Newman–
Keuls or Bonferroni’s post-hoc test were performed as ap-
propriate. The Spearman’s rank correlation coefficient was
calculated to measure the strength of relationship between
levels of Aqp1 expression and time. All aforementioned
analyses were performed using the Graphpad prism 5 stat-
istical program (GraphPad Software, Inc., La Jolla, CA,
USA). All P values are two-sided; P <0.05 was considered
significant.
Results
Gene expression profiling in the initial polytrauma
patients
Isolated RNA from total blood cells (>95% leukocytes) of
the initial five polytrauma patients was hybridized to
DNA microarrays (Affymetrix Hu133A 2.0) and genes
with statistically significant changes in their expressionin all patients were selected as described in detail in
Additional file 1. Patients’ age was 21.75 ± 2.5 and mean
ICU stay was 13 ± 5.2 days. Two of the patients devel-
oped sepsis while three developed severe sepsis and
acute respiratory distress syndrome [2,4,17]. The two
and three patient subgroups were analyzed independ-
ently (see Additional file 1) to detect genes that were dif-
ferentially regulated between them, and which could
be involved in pathogenetic mechanisms of the septic
process and acute respiratory distress syndrome. We
thus found 1,199 genes with statistically significant dif-
ferences among the replicate values of fold-changes of
the two separate patient subgroups (P < 0.05; false dis-
covery rate 5%) (Additional file 1: Table S1).
To validate the selected genes, we compared our re-
sults with published expression profiling studies using
animal models of LPS-induced and aseptic lung injury,
as described in Additional file 1. The comparison ana-
lysis yielded three genes that were commonly identified
as deregulated both in human patients with severe sepsis
and acute respiratory distress syndrome, as well as ex-
perimental rodents: the orphan G-protein coupled re-
ceptor 182; the dedicator of cytokinesis protein 9, a
Cdc42 guanine nucleotide exchange factor; and Aqp1, a
28 KDa water channel protein.
Aqp1 gene expression in septic ICU patients
Since little is known regarding Aqp1 expression in leu-
kocytes, we initially performed PCR on RNA isolated
from leukocytes of ICU patients in order to confirm the
findings of the gene expression analysis. Aqp1 expres-
sion was indeed detected in human leukocytes by end-
point PCR (Figure 1A), in patients who either developed
sepsis or did not. GAPDH was used as a positive control
in the PCR reaction (Figure 1B).
Following confirmation that Aqp1 is expressed in hu-
man leukocytes, we prospectively followed temporal
trends in Aqp1 mRNA levels using quantitative real-
time PCR in ICU patients who were initially nonseptic
but later developed nosocomial sepsis and subsequently
septic shock (Figure 2A); mRNA levels of ICU patients
who did not develop sepsis, upon ICU admission and
discharge, are shown in Figure 2B. All 16 patients who
developed sepsis and then septic shock had positive bio-
logical fluid cultures, with 11 out of 16 having positive
blood cultures. In one-half (8/16) of our patients, sepsis
originated from lung infection; no difference in Aqp1 ex-
pression was noted in relation to the site of infection
(data not shown).
Two of the 16 patients received short-term treatment
(1 and 2 days, respectively) with short half-life steroids
during their ICU stay. These regimens were far from the
time points of Aqp1 expression measurements. Clinical
characteristics of the patients are listed in Table 1. For
Figure 1 Expression of aquaporin-1 in peripheral leukocytes of
septic and nonseptic patients. Representative expression analysis
of aquaporin-1 (Aqp1) and glyceraldehyde 3-phosphate
dehydrogenase (GAPDH) mRNAs in a nonseptic patient and a septic
patient. End-point PCR was performed on RNA isolated from
leukocytes of both patients at different time points (B, baseline; D,
discharge; S, 6 to 12 hours from sepsis; SS, upon septic shock) and
the end products were analyzed on a 2.5% agarose gel. (A)
Expression of Aqp1 messenger RNA in peripheral leukocytes of one
nonseptic patient and one septic patient. Lanes 1 and 2, nonseptic
patient; lane 3, molecular weight standards; lanes 4 to 6, septic
patient. (B) GAPDH was used as a positive control. Lanes 1 and 2,
nonseptic patient; lanes 3 to 5, septic patient.
Vassiliou et al. Critical Care 2013, 17:R199 Page 6 of 11
http://ccforum.com/content/17/5/R199each patient, Aqp1 levels on admission (baseline) are set
as the reference value and the subsequent time points
are expressed as the fold-change relative to this. Admis-
sion Aqp1 levels in ICU patients did not differ signifi-
cantly from healthy blood donors (data not shown), nor
did the baseline levels of patients who developed sepsis
differ from the baseline levels of patients who did not
develop sepsis (data not shown). However, upon onsetFigure 2 Aquaporin-1 expression is induced in leukocytes of patients
septic shock patients at three different time points (baseline, 6 to 12 hours
levels in nonseptic patients at two different time points (baseline and disch
leukocyte Aqp1 levels at discharge did not exceed admission levels. In pati
admission to the onset of sepsis and, up to the onset of septic shock. Data
25th to 75th centiles; whiskers, range of values. *P <0.05, **P <0.01 from ba
tested by the Friedman test (more than two groups) and the Wilcoxon sigof sepsis, we observed a median 1.7-fold (interquartile
range: 0.99 to 2.4) increase in Aqp1 mRNA (P = 0.012)
(Figure 2A). Aqp1 mRNA was also measured upon sep-
tic shock and was further elevated, corresponding to a
median increase of 3.00-fold (interquartile range: 1.20 to
5.40, P = 0.002 from baseline and P = 0.023 from sepsis)
(Figure 2A). Conversely, in patients who did not develop
sepsis, Aqp1 expression at discharge did not differ from
admission levels (median 0.99-fold, interquartile range:
0.32 to 1.24; Figure 2B). In the latter group, two add-
itional patients also received short-term treatments of
comparable duration with those of the septic subjects,
with short half-life steroids. Spearman’s rank correlation
coefficient revealed no statistically significant relation-
ship between time (days) in the ICU and levels of Aqp1
expression in both groups.Aqp1 mRNA and protein expression in human
PMNs stimulated by lipopolysaccharide
Since Aqp1 appears upregulated in leukocytes from
critically ill patients with nosocomial, mostly Gram-
negative sepsis, we probed the role of LPS as an Aqp1
inducer. PMNs, particularly neutrophils, by virtue of
their abundance and immediate responsiveness with
genomic alterations to bacterial pathogens, became the
focus of these studies. After confirming that Aqp1 is
expressed in PMNs by end-point PCR (Figure 3A),
healthy-donor PMNs were stimulated by LPS (100 ng/
ml for 3 hours) in vitro and Aqp1 mRNA levels were
determined by quantitative real-time PCR. In five inde-
pendent repetitions of this experiment, Aqp1 mRNA
expression rose by fourfold on average in the presencewith sepsis. (A) Distribution of aquaporin-1 (Aqp1) mRNA levels in
from sepsis and upon septic shock). (B) Distribution of Aqp1 mRNA
arge). In patients whose ICU stay was not complicated by sepsis,
ents who developed sepsis, however, Aqp1 levels rose steadily from
are presented as box plots. Line in the box, median value; box edges,
seline values. #P <0.05 from sepsis. Differences within groups were
ned-rank test (two groups).
Figure 3 Expression of aquaporin-1 mRNA and protein in polymorphonuclear granulocytes is induced by lipopolysaccharide.
Polymorphonuclear granulocytes (PMNs) isolated from healthy blood donor volunteers were incubated for 3 hours at 37°C in six-well plates with
plain cell-culture medium (ctr) or lipopolysaccharide (LPS) from Pseudomonas aeruginosa in the absence or presence of NF-κB inhibitor EF-24.
(A) Representative expression of aquaporin-1 (Aqp1; upper panel) and glyceraldehyde 3-phosphate dehydrogenase (GAPDH; lower panel) mRNAs.
End-point PCR was performed on RNA isolated from PMNs, as above and analyzed on 2.5% agarose gel. (B) Fold-increase of Aqp1 gene
expression, as measured by real-time PCR in PMNs. (C) Increase in protein expression of Aqp1 in crude protein samples isolated from PMNs, as
analyzed by SDS-PAGE and immunoblotting. Relative Aqp1 protein expression was estimated by densitometry using β-tubulin as a loading
control. **P <0.01 from corresponding control. #P <0.05 from corresponding LPS treatment by one-way analysis of variance followed by
Newman–Keuls multiple comparison test.
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phils) (Figure 3B). This was also associated with an in-
crease in Aqp1 protein levels in LPS-stimulated PMNs as
detected by immunoblotting (Figure 3C).
Binding of LPS on Toll-like receptor-4 leads to NF-
κB-mediated transcription of target genes, including IL-
8; the latter was, in fact, found increased in cell culture
supernatants in our experiments (Figure 4A), in support
of NF-κB activation in our system (Figure 4B). Suppres-
sion of NF-κB activity by EF-24 (Figure 4B), through
direct inhibition of IκB kinase, prevented Aqp1 mRNA
induction (Figure 3B) and protein expression induced
by LPS (Figure 3C), and IL-8 release (Figure 4A).
Cell volume measurements
We next examined whether the induction of Aqp1 water
channel expression by LPS invoked functional changes in
PMN plasma membrane permeability. As a surrogate formembrane permeability, we measured PMN relative vol-
ume V/Vo in serial micrographs in response to a hypo-
tonic challenge, facilitated by lowering cell culture
medium osmolarity from 300 to 150 mOsm/lt. This inter-
vention was associated with a 1.8-fold rise in V/Vo,
followed by return to the initial dimensions by 600 sec-
onds (Figure 5). With LPS stimulation, however, the
PMN V/Vo increase was more pronounced (2.2-fold)
and did not return to the baseline value during the 600-
second observation time (Figure 5, P <0.001) The LPS-
triggered permeability response of PMN was inhibited
by incubation with HgCl2 (0.3 mM for 5 minutes),
which is known to block permeability of the Aqp1 water
pore by forming a covalent attachment with cysteine
189 in the native molecule [16]. Furthermore, incubation
for 15 minutes in 5 mM β-mercaptoethanol (Figure 5,
three independent experiments, P <0.05), a reducer of pro-
tein disulfide bonds, abrogated the action of mercury
Figure 4 Polymorphonuclear granulocytes are activated by
lipopolysaccharide via NF-κB. Polymorphonuclear granulocytes
(PMNs) isolated from healthy blood donors were incubated for 3
hours at 37°C in six-well plates with plain cell-culture medium (ctr)
or lipopolysaccharide (LPS) from Pseudomonas aeruginosa in the
absence or presence of the NF-κB inhibitor EF-24. (A) IL-8 levels
measured by ELISA on PMN supernatants. (B) NF-κB activation as
measured by the NF-κB (p65) transcription factor assay on PMN
nuclear extracts, expressed as increase of absorbance at 450 nm
relative to total protein concentration. The increase in absorbance at
450 nm indicates translocation of NF-κB into the nucleus and DNA
binding activity in the nuclear extracts. *P <0.05 from corresponding
control. #P <0.05, ##P <0.01 from corresponding LPS treatment by
one-way analysis of variance (ANOVA) followed by Newman–Keuls
multiple comparison test or two-way ANOVA for repeated measures
followed by Bonferoni’s post-hoc test.
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Cys189, and restored the effects of LPS.
Discussion
Hospital-acquired sepsis is a major cause of mortality in
critically ill patients. It is becoming increasingly evident
that critical illness is associated with a state of functional
immunosuppression [3,18,19], possibly following an acute
phase of disproportionate immune system activation. This
paradigm has triggered interest in mechanistic under-
standing of immune system (dys)function in sepsis. In this
context, we initially undertook gene expression profiling
in a small sample of polytrauma patients, who subse-
quently acquired sepsis, which returned a large set ofgenes with differential expression between patients who
developed sepsis versus severe sepsis. Owing to the limited
size of this pilot study, and the variability inherent to this
methodology, we compared our dataset with published
work in animal models of acute insults relevant to the
ICU population, such as LPS-induced lung injury, a com-
mon organ failure in severe sepsis, using the ortholog gene
approach. We were thus able to identify Aqp1 as a gene
differentially expressed in experimental animals and
humans on a consistent basis, indicating a potential in-
volvement in the acute phase response. Importantly,
Aqp1 upregulation seems to take place not only in lung
tissue [20] but, as shown in our study, also in leuko-
cytes, suggesting a potentially fundamental role in cellu-
lar adaptation to acute stress. Although Aqp1 can be
found in various tissues and cell types, most notably red
blood cells, renal tubules and endothelial cells [7,21-24],
details on Aqp1 expression patterns and functional roles
in leukocytes have not yet been described.
Aquaporins regulate cell membrane permeability in
most cell types. Most isoforms are selective to water, al-
though some, including aquaporin-7 and aquaporin-9,
are permeable to other micromolecules, including urea
and glycerol [25]. Leukocytes are known to express
aquaporin-9, which is crucial to the formation of filo-
podia, finger-like membrane protrusions involved in
cytokinesis [26,27]. We here report the inducible expres-
sion of Aqp1 in leukocytes in clinical sepsis and in re-
sponse to LPS in vitro. This finding reveals a hitherto
unknown and potentially fundamental function of this
molecule in innate immunity.
To validate the results of the initial pilot gene expression
study and meta-analysis, we prospectively followed Aqp1
expression in leukocytes of critically ill patients who were
not septic upon ICU admission. We observed an increase in
Aqp1 mRNA expression with the appearance of sepsis and
septic shock. This effect was not dependent on the length of
ICU stay, but was related to the septic process severity and
strongly implies that Aqp1 is inducible in humans in the
context of the immune response to infection.
Induction in Aqp1 was recently reported by Madonna
and coworkers [28] in mouse hearts following septic en-
dotoxemia. In contrast, Aqp1 was found downregulated in
human pleural mesothelial cell lines (MET-5A) and pri-
mary rat lung microvessel endothelial cells following LPS
administration [29,30], as well as in rat and murine models
of LPS-induced lung injury [30,31]. In spite of these dispar-
ities, which may merely reflect tissue-specific effects of the
molecule and differences in experimental design, the data
support a novel role for this protein in the stress response
to sepsis.
Since ICU-acquired sepsis is most commonly caused by
LPS found in Gram-negative bacteria, we tested the role
of LPS as an Aqp1 inducer in human PMNs. We found a
Figure 5 Time-course and Hg2+ inhibition of osmotic swelling of polymorphonuclear granulocytes. (A) Time course and Hg2+ inhibition of
osmotic swelling of polymorphonuclear granulocytes (PMNs) that were incubated for 3 hours at 37°C either in the absence (control) or presence of
lipopolysaccharide (LPS). Cells were then transferred to a hypotonic solution and changes in size were measured by videomicroscopy (see Materials
and methods). Where indicated, PMNs were incubated for 5 minutes in buffer containing 0.3 mM HgCI2, followed by swelling in the presence of HgCI2
(LPS + HgCI2). After incubation for 5 minutes in 0.3 mM HgCI2, other PMNs were then incubated for 15 minutes in buffer containing 5 mM
β-mercaptoethanol and swelling was monitored in the presence of β-mercaptoethanol (LPS + HgCI2 + β-merc). Cells were assumed to have a
spherical shape with a diameter calculated as the average of the maximum and minimum dimensions of each cell. *P <0.05, ***P <0.001 from control
by two-way analysis of variance for repeated measures followed by Bonferoni’s post-hoc test. (B) Microscopy photographs of the time course and
osmotic swelling of PMNs (original magnification ×80).
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Aqp1 by LPS. This was abrogated by pharmacological dis-
ruption of NF-κB signaling pathway, known to transduce
signals downstream of the Toll-like-receptor 4, implying
that LPS stimulates Aqp1 expression via NF-κB activation.
LPS measurably stimulated PMNs, as indicated by a signifi-
cant increase of IL-8 production and activation of NF-κB.
Placing naive cells in a hypoosmotic environment results
in a time-dependent and HgCl2-sensitive increase in cell
volume. This transient effect is followed by a gradual de-
cline to the baseline values, possibly as a result of a com-
pensatory escape of water and osmotically active molecules
from the cell or derecruitment of Aqp1 from the cell mem-
brane. In the presence of LPS, however, membrane perme-
ability remained increased throughout the observation
period (600 seconds), consistent with excess Aqp1.
The implications of LPS-induced cell membrane perme-
ability on PMN function in sepsis are unknown. Besidespermeability, however, Aqp1 could regulate the PMN
stress response by other putative mechanisms. In this con-
text, Aqp1 contributes to endothelial cell migration [32]
by forming a critical scaffold for a plasma membrane-
associated multiprotein complex important for cytoskel-
eton remodeling, adhesion and motility. Additionally, the
formation of filopodia depends on assembly of an actin
cytoskeletal scaffold to support the cell membrane protru-
sion. An early event in protrusion formation is a local in-
crease in water permeability facilitated by aquaporins,
which are thus critical to cell motility [33]. The theoretical
significance of the herein demonstrated induction of Aqp1
may be to enhance the neutrophil’s ability to migrate to
sites of infection. However, additional involvement in neu-
trophil activation (for example, phagocytosis and oxidative
burst) and resistance to apoptosis [34] cannot be excluded.
Our study has the following limitations. The popula-
tion of our initial study on gene expression profiling
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tation of funds. However, analysis identified genes,
among them Aqp1, with statistically significant changes
in their expression. Expression of Aqp1 in patients was
probed in total leukocytes isolated from blood, whereas
in vitro studies were performed on the PMN fraction,
which contains mostly neutrophils. Nevertheless, it should
be noted that leukocytes from septic patients are mainly
neutrophils. Aside from this being one of the first reports
of Aqp1 expression in human leukocytes and PMNs, our
results document that sepsis and LPS are associated with
Aqp1 induction in leukocytes and neutrophils and this
could be an important event in neutrophil activation in the
setting of sepsis, as well as a biomarker of the latter. Further
studies on the regulation of the Aqp1 signal transduction
pathway and functional significance may enhance our un-
derstanding of the host’s immune response, which appears
crucial to the outcome of this devastating syndrome.
Conclusions
Based on sepsis-specific overexpression, we propose
that increased levels of leukocyte Aqp1 may play a role
in sepsis. Aqp1 is upregulated in leukocytes of critically
ill patients with hospital-acquired sepsis, while in vitro
studies support triggering by LPS and transcriptional
regulation by ΝF-κB. Aqp1 induction is moreover asso-
ciated with increased cell membrane permeability and
may therefore be of probable functional significance.
Key messages
 Aqp1 is upregulated in leukocytes of critically ill
patients with ICU-acquired sepsis.
 In PMNs from healthy donors stimulated with LPS, a
statistically and biologically significant upregulation of
Aqp1 is observed.
 By disrupting NF-κB signaling in PMNs, we found
that Aqp1 was no longer upregulated, indicating
that LPS can directly increase Aqp1 expression via
NF-κB activation.
 Increased Aqp1 expression leads to increased PMN
cell membrane permeability.Additional file
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